CDCatherine Daniel
Catherine Daniel
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Catherine Daniel has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Matthieu Carton
Institut Curie, PSL Research University, DRCI, Biométrie, Saint-Cloud, France
2 shared publications N. Girard
Oncology Department, Institut Curie, Paris, France
2 shared publicationsP. Du Rusquec
Oncology Department, Institut Curie, Paris, France
2 shared publicationsA. Burnod
Palliative Care Department, Institut Curie, Paris, France
1 shared publicationA. Livartowski
Data Department, Institut Curie, Paris, France
1 shared publicationA. Martin
Palliative Care Department, Institut Curie, Paris, France
1 shared publication
Latest Publications
- Open Access
- 29 June 2024
- Published by Elsevier in Lung Cancer
- Vol. 194, 107866
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial
- 29 June 2024
- Published by Elsevier in Lung Cancer
- Vol. 194, 107866
Open AccessReal-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial
- Open Access
- 24 April 2024
- Published by Elsevier in Lung Cancer
- Vol. 192, 107800
Palliative care integration and end-of-life care intensity for patients with NSCLC
- 24 April 2024
- Published by Elsevier in Lung Cancer
- Vol. 192, 107800
Open AccessPalliative care integration and end-of-life care intensity for patients with NSCLC
- Open Access
- 2 April 2022
- Published by Elsevier in Annals of Oncology
- Vol. 33, S57
54P Overall survival in patients with metastatic lung cancer from 2000 to 2020: Implementation of innovative strategies in a real-world setting
- 2 April 2022
- Published by Elsevier in Annals of Oncology
- Vol. 33, S57
Open Access54P Overall survival in patients with metastatic lung cancer from 2000 to 2020: Implementation of innovative strategies in a real-world setting